Meet the speakers

Prof Ayal Hendel is a leading researcher in genome editing and gene therapy at BarIlan University in Ramat Gan, Israel. He earned his PhD from the Weizmann
Institute of Science and completed postdoctoral work at Stanford University, where he contributed to early advances in CRISPR Genome Editing.

Dr Anne Kasyoka Barasa is a Consultant Pathologist and Lecturer at the University of Nairobi Faculty of Health Sciences, where she serves as the Head of the Unit of Immunology within the Department of Human Pathology.

Prof Jettanong Klaewsongkram is a Professor of Medicine and Head of the Division of Allergy and Clinical Immunology at Chulalongkorn University. His research focuses on drug allergy, severe cutaneous adverse reactions (SCARs), and immune dysfunction in immunodeficient patients.

Dr David Lowe completed specialist clinical training in Infectious Diseases in London and undertook a PhD in Immunology (predominantly looking at neutrophil function) in the UK and Cape Town, South Africa.

Pamela Lee is a Clinical Associate Professor in the Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong
Honorary Consultant, Department of Paediatrics and Adolescent Medicine, at the Queen Mary Hospital, Hong Kong.

Prof Singh is a distinguished paediatric leader, heading the Paediatrics Department and Paediatric Allergy/Immunology Unit at PGIMER, Chandigarh.

Johan Prevot has worked in the healthcare sector for 20 years in the field of patient advocacy and health policy. Johan Prevot is the Executive Director of the International Patient Organisation for Primary Immunodeficiencies (IPOPI).

Martine Pergent is currently the President of IPOPI and was elected in October 2018 after serving eight years as IPOPI Vice-President. She has wide experience in patient advocacy and is particularly committed to raising awareness on PIDs as rare conditions, improving access to early and accurate diagnosis and personalised treatment, encouraging, and supporting the creation of new patient organisations, especially committed to low- and middle-income countries.

Antonio Condino-Neto, MD, PhD, FAAAAI, FCIS, is a distinguished physician and immunologist with a strong academic background, holding a PhD in Pharmacology and a Master’s in Immunology.

He received his MD, PhD and had his training in Paediatrics and in Paediatric Rheumatology in Italy. After spending 2 years at the NIH, he worked in Pavia, Italy, at the Department of Paediatrics.

Assoc Prof Dr Adli Ali heads the clinical immunology services and serves as the main research coordinator in the newly established UKM Specialist Children’s Hospital. His clinical work focuses on care for patients with primary and secondary immunodysregulation disorders, autoimmune, allergy diseases, emerging infectious diseases and vaccinology.

Martin Zach is a philosopher of science working on conceptual issues in immunology, especially how current knowledge is transforming our understanding of the immune system. His recent publications include work on immune metaphors and frameworks (Bio & Phil), asymptomatic infections (PhilMed), and the concept of antibodies (Immunol Rev).

Nicholas L Rider is a board-certified clinical immunologist and clinical informaticist. He has longstanding expertise in the clinical management of patients with complex immunologic disease and in clinical data science approaches for optimizing patient care.

Siobhan Burns is the Professor of Translational Immunology at University College London. She is a clinical academic with an interest in primary immunodeficiency disorders (PID). Originally trained in paediatric immunology, she worked at UCL Institute of Child Health
and Great Ormond Street Hospital before moving to the Institute of Immunity and Transplantation and the Adult Clinical Immunology department at the Royal Free Hospital, London.

As Head of the LETIS laboratory he is dedicated to pioneering research in regenerative medicine and organ transplantation. His academic journey commenced in Amsterdam, where he studied Biology at the University of Amsterdam and completed his PhD in Immunology at the VU in 1998. With over 240
international peer-reviewed publications, he has garnered numerous national and international scientific awards including the ILTS Basic Science Award.

Prof Tangye studies the biology of human immune cells in health and disease, aiming to understand how defects in single genes – inborn errors of immunity – result in various immune diseases. His research outcomes include elucidating critical roles for specific genes in the generation and function of human memory B cells and CD4+ T cells in response to infection and/or vaccination, and anti-viral immunity mediated by CD8 + T cells.

Steven M Holland, M.D., is the Director of the Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Prior to becoming Director, DIR, NIAID, Dr. Holland served NIAID as Chief of the Laboratory of Clinical Infectious Diseases (LCID). Dr Holland continues to lead a program in NIAID as chief of its Immunopathogenesis Section in the Laboratory of Clinical Immunology and Microbiology.

Dr Dalm is a renowned physician and researcher specialising in clinical immunology and primary immunodeficiency (PID) at Erasmus University Medical Center Rotterdam. With over 10 years of experience, he focuses on identifying genetic defects underlying PIDs to develop targeted treatments.